Latest Breaking News On - Project optimus - Page 1 : comparemela.com

First-in-Class PARP1 Selective Inhibitor Saruparib Shines in Phase 1 Trial of Advanced Solid Tumors

Timothy Yap, MBBS, PhD, FRCP, discusses encouraging data seen with the first-in-class PARP1 selective inhibitor saruparib in solid tumors and how the agent is being further investigated.

United statesTimothy yapTherapeutics discovery divisionTranslational researchUniversity of texas md anderson cancer centerKhalifa institute for personalized cancer therapyClinical developmentInvestigational cancer therapeuticsPhasei programNeck medical oncologyCancer centerKhalifa institutePersonalized cancerProject optimus

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin

United statesSan franciscoJulie bullockLauren jei mccarthyMark ratainKevan shokatJulie gralowMichael grantStephen shivinskyRichard pazdurKaiser permanenteDonald harveyJill feldmanDon crosslinAaaron smithEmory harvey

Active Biotech : Interview with Prof Dr Axel Glasmacher, Independent Board Member at Active Biotech

Active Biotech : Interview with Prof Dr Axel Glasmacher, Independent Board Member at Active Biotech
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNordrhein westfalenRebekka schneider kramannCelgene medical affairsUniversity of bonnMd anderson cancer centerCancer drug development forumGlobal clinical researchUniversity clinic in bonnHead of medical affairs in europeActive biotechUniversity clinicMedical directorMedical affairsMiddle eastTherapeutic area head myeloid diseases

Amgen plows ahead with costly, highly toxic cancer drug dosing despite FDA challenge

Amgen plows ahead with costly, highly toxic cancer drug dosing despite FDA challenge
suntimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from suntimes.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoFlagler beachDon crosslinKevan shokatJulie bullockDonald harveyAaaron smithMark ratainJill feldmanJulie gralowLauren jei mccarthyRichard pazdurEmory harveyKaiser permanenteStephen shivinsky

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
dailydemocrat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailydemocrat.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoEmory harveyStephen shivinskyJulie bullockLauren jei mccarthyMark ratainKaiser permanenteKevan shokatJill feldmanDonald harveyRichard pazdurAaaron smithMichael grantJulie gralowDon crosslin